SAN MATEO, Calif., Oct. 20 AlphaDetail, an innovator in pharmaceutical marketing research, is pleased to introduce two new features to its suite of tracking services: AlphaLink and AlphaMonitor.
AlphaLink helps clients better understand their competitive landscape by integrating secondary research with tracking study results. "One of the biggest issues facing clients today is managing through vast amounts of data, gathered from a number of different sources," says Rishi Varma, co-founder of AlphaDetail. "AlphaLink provides an integrated view of a market, enabling a more focused, holistic market understanding."
AlphaMonitor provides real-time online access with up-to-the-minute results for any of the company's tracking services - from continuous tracking to monitoring key variables in periodic tracking studies. "Pharmaceutical and biotech marketers are frequently looking for fast insights to react to market changes," reports Dave Johnson, Vice President of AlphaDetail's Professional Services team. "AlphaMonitor offers instant views and dynamic access to study results that enable marketers to quickly understand and react to feedback from the market."
To learn more about AlphaDetail's Tracking services, please contact Bob Latshaw at [email protected]
or (215) 259-5601, or visit us at http://www.alphadetail.com/corp/Home.do
About AlphaDetail, Inc.:
AlphaDetail, Inc. is an innovator in primary market research and KOL Identification serving the global biopharmaceutical industry. AlphaDetail's expertise spans every continent, a wide array of therapeutic areas and every stage of the product life cycle. Our clients include the top pharmaceutical, biotech and medical device companies in the world, as well as companies of all sizes. AlphaDetail is built on one of the industry's strongest foundations that include a large team of exceptional analytical specialists, the industry's leading technology platform and a flexible approach to research that helps us to answer our client's most challenging questions.
SOURCE AlphaDetail, Inc.